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p13suc1 (Cks) proteins have been implicated in the regulation of cyclin-dependent kinase (CDK) activity.
However, the mechanism by which Cks influences the function of cyclin-CDK complexes has remained elusive.
We show here that Cks1 is required for the protein kinase activity of budding yeast G1 cyclin-CDK complexes.
Cln2 and Cdc28 subunits coexpressed in baculovirus-infected insect cells fail to exhibit protein kinase activity
towards multiple substrates in the absence of Cks1. Cks1 can both stabilize Cln2-Cdc28 complexes and activate
intact complexes in vitro, suggesting that it plays multiple roles in the biogenesis of active G1 cyclin-CDK
complexes. In contrast, Cdc28 forms stable, active complexes with the B-type cyclins Clb4 and Clb5 regardless
of whether Cks1 is present. The levels of Cln2-Cdc28 and Cln3-Cdc28 protein kinase activity are severely
reduced in cks1-38 cell extracts. Moreover, phosphorylation of G1 cyclins, which depends on Cdc28 activity, is
reduced in cks1-38 cells. The role of Cks1 in promoting G1 cyclin-CDK protein kinase activity both in vitro and
in vivo provides a simple molecular rationale for the essential role of CKS1 in progression through G1 phase
in budding yeast.
Cyclin-dependent kinases (CDKs) trigger a variety of events
in the division cycle of eukaryotic cells (28). Multiple regula-
tory mechanisms conspire to ensure that CDKs are switched
on at the right time and in the right place as cells proceed
through the cell division program. At least four distinct post-
translational mechanisms positively regulate CDK function,
including binding of cyclins, binding of p13suc1 (Cks) proteins,
phosphorylation of a threonine within the T-loop of CDKs by
the CDK-activating kinase (CAK), and dephosphorylation of
threonine and tyrosine residues within the ATP-binding site by
Cdc25 (27). Of these mechanisms, the least well understood is
how binding of Cks proteins promote the function of CDKs.
The gene encoding p13suc1 was originally identified as a
multicopy suppressor of cdc2ts mutations in Schizosaccharomy-
ces pombe (15) and was subsequently isolated as a multicopy
suppressor (named CKS1) of cdc28ts mutations in Saccharo-
myces cerevisiae (14). Characterization of budding yeast cks1
thermosensitive mutants revealed that Cks1 function is re-
quired at two points in the cell cycle: prior to start in G1 and at
some point in mitosis (42). As was observed in p13suc1-de-
pleted fission yeast (26), G2-arrested cks1
ts mutants accumu-
late high levels of CDK activity.
The role of Cks proteins in progression through mitosis has
been the subject of numerous recent studies. Xenopus extracts
depleted of the Cks1 homolog p9 fail to enter mitosis due to
accumulation of inhibitory phosphate on the Y15 residue of
p34cdc2 (29), perhaps because p9 promotes CDK-dependent
phosphorylation of the Y15 kinase Wee1 and the Y15 phos-
phatase Cdc25 (31). p9-depleted cycling extracts programmed
with a p34cdc2 mutant that cannot be phosphorylated on Y15
no longer arrest at the G2/M transition but instead fail to
initiate cyclin B destruction and consequently remain arrested
in mitosis (29). These results suggest that p9 also promotes
activation of cyclin B proteolysis by the anaphase-promoting
complex–cyclosome (APC/C)–26S proteasome pathways (22).
p9 is thought to activate cyclin B proteolysis by directly facili-
tating the phosphorylation of components of the APC/C, in-
cluding Cdc27, by mitotic CDK (30, 36). However, there is
some controversy on this point, since budding yeast Cks1 is
dispensable for cyclin B ubiquitination but appears instead to
promote degradation of ubiquitinated cyclin B by the 26S pro-
teasome (19). Despite these recent advances in our under-
standing of how Cks proteins promote mitosis, it remains un-
clear why Cks1 is required for progression through Start.
Structural insights into the function of Cks proteins have
emerged from X-ray crystallography of human Cks1-Cdk2
complexes (2). The binding of Cks1 does not cause significant
conformational changes in either the active site or the cyclin-
binding interface of Cdk2. A comparison of the Cks1-Cdk2 and
cyclin A-Cdk2 (17) structures reveals that Cks1 and cyclin A
bind to opposite sides of Cdk2 flanking the active site (2). The
structure of the ternary complex suggests that Cks1 may help
position substrates for phosphorylation by Cdk2.
In this report, we provide evidence that Cks1 is required
both in vitro and in vivo for the protein kinase activity of G1
cyclin-CDK complexes from budding yeast. These findings sug-
gest a simple explanation for why Cks1 activity is required for
budding yeast cells to traverse Start.
MATERIALS AND METHODS
Preparation of cell lysates from baculovirus-infected cells. Sf9 or Hi-5 cells
were grown in suspension in supplemented Grace’s insect media. For infection,
107 cells were plated per 10-cm-diameter dish and overlayed with working stocks
of viruses at a multiplicity of infection of ;10. After incubation for 40 to 44 h,
cells were harvested in a clinical centrifuge at 4°C, washed once in 13 phosphate-
buffered saline, and resuspended in ice-cold lysis buffer (10 mM HEPES-KOH
[pH 7.4], 150 mM NaCl, 0.2% Triton X-100, 1 mM b-mercaptoethanol, 5 mg of
pepstatin and 5 mg of leupeptin/ml, 2 mM phenylmethylsulfonyl fluoride
(PMSF), 2 mM benzamidine, 50 mM b-glycerophosphate, 50 mM NaF, and 0.2
mM sodium orthovanadate). After a 10-min incubation on ice, lysates were
sonicated three times for 10-s intervals at a setting of 4 (Branson sonifier 450)
and then clarified by centrifugation at 4°C (35,000 rpm for 10 min; Sorvall
RP100AT4 rotor). Supernatant fractions (typically 4 to 10 mg of protein/ml)
were frozen in liquid N2 and stored at 280°C.
Activation of Cln2-Cdc28HA, immunoprecipitations, protein kinase assays,
and immunoblots. Clarified lysates from baculovirus-infected Sf9 cells were
incubated in a reaction mixture consisting of activation buffer (1/10 volume of 40
mM magnesium acetate, 5 mM PMSF, 50 mM benzamidine, 10 mM dithiothre-
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itol (DTT), 50 mg of pepstatin and 50 mg of leupeptin/ml), with or without yeast
extract, Cks1, and ATP-regenerating system (1/10 volume of 500-mg/ml creatine
phosphokinase, 10 mM ATP, 20 mM HEPES [pH 7.2], 10 mM magnesium
acetate, 300 mM creatine phosphate). Activation mixtures were incubated for 15
min at 24°C and then chilled on ice.
For immunoprecipitation and histone H1 kinase assays, 3 to 10 ml of a 10-ml
activation reaction mixture was diluted with 200 ml of immunoprecipitation
buffer (IPB; 50 mM b-glycerophosphate [pH 7.5], 100 mM NaCl, 50 mM NaF, 5
mM EDTA, 2 mM sodium orthovanadate, 0.2% Triton X-100, 1 mM DTT, 0.5
mM PMSF, 5 mg of pepstatin and 5 mg of leupeptin/ml) and supplemented with
0.75 ml of 12CA5 antihemagglutinin (anti-HA) ascites fluid. After a 45-min
incubation on ice, 20 ml of a 50% slurry of protein A-Sepharose beads was added,
and tubes were incubated on a rotating wheel for 1 h at 4°C. Immune complexes
were washed twice with 1 ml of IPB (minus protease inhibitors, NaF, and sodium
orthovanadate). All samples were then washed twice with 1 ml of kinase assay
buffer (KAB; 10 mM HEPES [pH 7.2], 10 mM MgCl2, 50 mM NaCl, 2 mM
EDTA, 1 mM DTT, 0.02% Triton X-100) and supplemented with 10 ml of KAB
adjusted to 150 mg of histone H1/ml, 11 mM ATP, and 1.5 mCi of [g-32P]ATP
(4,500 Ci/mmol)/ml. Following a 15-min incubation at room temperature, kinase
reactions were terminated by addition of 7 ml of 33 sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) loading buffer and heated for 3
min at 95°C. Boiled samples were subjected to SDS-PAGE, and the 32P radio-
label was quantitated by imaging dried gels with a Molecular Dynamics Phos-
phorImager.
Immunoblotting was performed with either anti-myc monoclonal antibody
9E10 (9) or anti-HA monoclonal antibody 12CA5 (11) ascites fluids (purchased
from BabCo) used at a dilution of 1/1,000 or affinity-purified anti-Cdc28 poly-
clonal antibodies. Filter-bound antibodies were visualized using horseradish per-
oxidase-conjugated secondary antibodies and Amersham’s enhanced chemilumi-
nescence (ECL) kit. For the experiment shown in Fig. 6C, Cln333HA
immunoreactivity was quantitated using a Molecular Dynamics STORM system.
Preparation of yeast extracts. Yeast extracts used as a source of Cln2-Cdc28
activator were prepared as described previously (5) from RJD875 (trp1 ura3 his2
ade1 bar1 cln1D cln2D cln3D leu2::GAL-CLN3::LEU2 cdc28-4 pep4::URA3
MATa) cells arrested in G1 by growth in yeast extract-peptone-dextrose (YPD)
medium for 5.5 h at 24°C.
To examine the effect of mutant Cks1 on Cln2-Cdc28 activity, we assayed the
level of Cln2-Cdc28 activity in extracts prepared from isogenic CKS1 and cks1-38
strains as follows. Yeast strains RJD1091 (BF264-15D; ade1 his2 leu2-3,112,
trp1-1a cks1::LEU2 cln2::CLN233HA::LEU2 MATa plus pSE271/cks1-38 [TRP1
CEN1 ARS cks1-ts38]) and RJD1093 (BF264-15D; ade1 his2 leu2-3,112 trp1-1a
cks1::LEU2 cln2::CLN233HA::LEU2 MATa plus pSE271/CKS1 [TRP1 CEN1
ARS CKS1]) were grown in 1 liter of YPD at 24°C to an optical density at 600 nm
(OD600) of ;0.5. Each 1-liter culture was split into two 500-ml cultures, one of
which was placed at 24°C and the other at 38.5°C, for 3.5 h. Cultures were
harvested by centrifugation (7 min at 7,000 rpm; Sorvall GSA rotor), and cell
pellets were washed once with 50 ml of ice-cold 100 mM NaCl, frozen in liquid
nitrogen, thawed, and resuspended in 3 ml of glass bead lysis buffer (GBLB; 18
mM Tris [pH 8.0], 8.8 mM MgCl2, 0.9 mM EDTA, 4.5% glycerol, 260 mM
ammonium sulfate, 88 mM NaCl, 50 mM NaF, 50 mM b-glycerophosphate, 0.2
mM sodium orthovanadate, 1 mM DTT, 2 mM PMSF, 2 mM benzamidine, 5 mg
of pepstatin and 5 mg of leupeptin/ml). The cell suspension was vortexed with 2
ml of glass beads (0.5 mm in diameter), and the resulting lysate was collected
from the beads and centrifuged at 4°C for 10 min in a microcentrifuge, followed
by 10 min at 40,000 rpm in a Sorvall microultracentrifuge (RP100AT4 rotor).
Clarified lysates were used for immunoprecipitation and immunoblotting of
Cln233HA as described in the legend to Fig. 5. Cln3-Cdc28 activities in untagged
(RJD539; ade1 his2 leu2 trp1 ura3 MATa), CKS1 CLN333HA (RJD1280;
cln3::LEU2::GAL1::CLN333HA cks1::LEU2 ade1 leu2 his2 trp1 ura3 MATa
pSE271-CKS1), and cks1-38 CLN333HA (RJD1279; cln3::LEU2::GAL1::
CLN333HA cks1::LEU2 ade1 leu2 his2 trp1 ura3 MATa pSE271-cks1-38) cells
were evaluated as described previously (18). RJD539, -1279, and -1280 are
isogenic to each other and to BF264-15d.
Cell extracts for the a-factor block-release experiment depicted in Fig. 5C and
D were prepared as follows. Yeast strains RJD1091 and RJD1093 were grown in
500 ml of YPD at 24°C to an OD600 of ;0.5, supplemented with 5 mg of
a-factor/ml, and incubated an additional 3 h at 24°C, followed by 1.5 h at 38.5°C.
G1-arrested cells were collected by filtration, washed with 500 ml of yeast extract-
peptone, and resuspended in 500 ml of YPD prewarmed to 38.5°C. At 15-min
intervals following release from a-factor, 45-ml aliquots of the culture were
harvested by centrifugation, and cell pellets were washed with 10 ml of 100 mM
NaCl and frozen in liquid nitrogen. Once aliquots at all time points were col-
lected, cell pellets were thawed, resuspended in 1 ml of GBLB, and lysed by
vortexing with 1 ml of glass beads (0.5 mm in diameter). Cell lysates were
clarified by centrifugation in a Sorvall microultracentrifuge (10 min at 35,000
rpm; RP100AT4 rotor) and used for immunoprecipitation and immunoblotting
of Cln233HA as described in the legend of Fig. 5.
Recombinant proteins. (i) Cks1. A 4-ml overnight culture of BL21(DE3) plus
pLysS transformed with the plasmid pCKS1-1, which expressed Cks1 from the T7
promoter, was inoculated into 1 liter of Luria broth–100 mg of ampicillin/ml and
grown at 37°C to an OD600 of 0.5. The culture was then cooled to 24°C in an ice
water bath, and IPTG (isopropyl-b-D-thiogalactopyranoside) was added to 0.3
mM to induce synthesis of Cks1. After a 4-h induction at 24°C, cells were
harvested (Sorvall GSA rotor; 7,000 rpm for 7 min), washed once with 250 ml of
50 mM Tris (pH 7.6)–100 mM NaCl, and resuspended in 10 ml of 13 phosphate-
buffered saline. To prepare a lysate, the cell suspension was frozen in liquid
nitrogen, thawed on ice, and sonicated for 30 s at setting 5 (Branson sonifier 450).
The resulting lysate was clarified by centrifugation in an IEC clinical centrifuge,
and the supernatant was incubated in a boiling-water bath for 5 min and then
centrifuged for 10 min at 40,000 rpm (Beckman 60Ti rotor). The supernatant
fraction was supplemented with ammonium sulfate (1 g per 6.1 ml of superna-
tant), incubated for 30 min at 4°C, and centrifuged at 40,000 rpm for 10 min
(Beckman 60Ti rotor). Precipitated proteins were redissolved in 10 ml of 50 mM
Tris (pH 7.6)–100 mM NaCl–2 mM EDTA and dialyzed against three changes of
50 mM Tris (pH 7.6)–100 mM NaCl. The dialysate was chromatographed on a
Sepharose CL-6B column (107 cm by 16-mm diameter), and fractions containing
Cks1 were pooled and concentrated in a 15-ml Millipore centrifugal concentrator
(nominal molecular mass cutoff 5 10 kDa).
(ii) Cdc28HA. A recombinant baculovirus that expresses Cdc28HA was gener-
ated by cloning a blunted, CDC28HA-containing BstBI/XbaI fragment from
pSF19 (39a) into the SmaI site of pVL1392.
(iii) Cln2mycHis6. Epitope-tagged Cln2 was generated by PCR amplification of
CLN2 from a pAS101 template (provided by A. Sil) using the oligonucleotides
RDO53 (GGGGGATCCCATATGGCTAGTGCTGAACC) and RDO54 (GG
GCTGCAGCTATATTACTTGCGGCCGCTGGGTATTGCCCATACC). The
resulting PCR fragment, which contains a unique NotI site at the 39 end of the
CLN2 coding sequence, was digested with BamHI plus PstI and subcloned into
the corresponding sites of pUC119 to generate pUC119-Cln2(NotI). Comple-
mentary oligonucleotides (RDO59: GGCCTCTAGAGGAGCAGAAATTAAT
CAGCGAAGAGGACCTCCTCAGGCATCATCACCATCATCACG; RDO60:
GGCCCGTGATGATGGTGATGATGCCTGAGGAGGTCCTCTTCGCTGA
TTAATTTCTGCTCCTCTAGA) encoding the bipartite mycHis6 epitope were
hybridized, kinased, and ligated into the unique NotI site of pUC119-
CLN2(NotI) to yield pUC119-CLN2mycHis6. Finally, the BamHI/PstI fragment of
pUC119-CLN2mycHis6 was cloned into the BamHI/PstI sites of pVL1393. All
PCR-amplified coding sequences were validated by DNA sequencing.
(iv) MBP-Clb2. CLB2 was amplified by PCR from a pC2408 template (pro-
vided by K. Nasmyth) using oligonucleotides RDO70 (GAACGGTCGACTCA
GAATTCTTCATGCAAGGTCATTATATCATAGCC) and RDO71 (GAACG
GCTAGCATATGTCGCGGCCGCTATCCAACCCAATAGAAAACAC). The
resulting fragment was digested with SalI plus NheI and cloned into the XbaI/SalI
sites of pRS306 (37), which had been previously modified by filling in the unique
NotI site (pRS306DNotI). All PCR-amplified coding sequences were validated by
DNA sequencing. CLB2 coding sequences were excised from this plasmid by
digestion with NdeI (filled in with Klenow fragment) and SalI and inserted into
the EcoRI (filled in with Klenow fragment) and SalI sites of pMAL-c1 (New
England BioLabs). Maltose-binding protein (MBP)–Clb2 was expressed and
purified on amylose resin by standard methods (New England BioLabs).
MBP-Sic1 was prepared as described previously (45). The Far1 fragment used
for kinase assays in Fig. 3 contained the 60 N-terminal amino acids of Far1
followed by a hexahistidine tag (provided by F. Cross). Far1(1-60)His6 was ex-
pressed and purified by nitrilotriacetic acid affinity chromatography as described
previously (Qiagen).
RESULTS
Activation of baculovirus-expressed Cln2-Cdc28 complexes
requires a factor from yeast extract. Cyclin-CDK subunits that
have been expressed from recombinant baculoviruses typically
assemble into active protein kinase complexes (4, 23, 25).
Thus, to characterize the budding yeast Cln2-Cdc28 complex,
we constructed recombinant baculoviruses to express Cln2 and
Cdc28 either singly or in combination in insect Sf9 cells. The
Cln2 and Cdc28 subunits were tagged at their C termini with a
dual myc-hexahistidine epitope (Cln2MH6) and an HA epitope
(Cdc28HA), respectively, to facilitate the recovery of Cln2-
Cdc28 complexes from cell lysates. Following immunoprecipi-
tation with the anti-HA monoclonal antibody 12CA5, immune
complexes were assayed for histone H1 protein kinase activity
and evaluated by SDS-PAGE (see Materials and Methods).
Unexpectedly, Sf9 cells coinfected with recombinant baculovi-
ruses encoding Cln2MH6 and Cdc28HA failed to express histone
H1 protein kinase activity (Fig. 1, lane 5), even though both
subunits were produced as judged by immunoblotting (data not
shown).
Recombinant glutathione S-transferase (GST)-Cln2 isolated
from Escherichia coli can activate Cdc28HA in crude yeast
extract (5). Thus, we examined whether yeast extract contains
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a factor that is required for the production of active Cln2-
Cdc28 protein kinase. Yeast extract prepared from a cdc28ts
mutant strain depleted of G1 cyclins was added to lysates
prepared from Sf9 insect cells coinfected with recombinant
baculoviruses encoding Cln2MH6 and Cdc28HA. Following a
brief incubation at 24°C in the presence of an ATP-regenerat-
ing system, Cdc28HA and associated proteins were recovered
and assayed for histone H1 kinase activity as described above.
Whereas the yeast extract itself had no 12CA5-precipitable
histone H1 kinase activity (Fig. 1, lane 1), it promoted the
recovery of active Cln2MH6-Cdc28HA from insect cell lysates
(lanes 6 to 8). No histone H1 kinase activity was recovered
upon incubation of yeast extract with Sf9 lysates containing
only Cdc28HA or Cln2MH6 (data not shown).
Budding yeast Cdc28 can potentially be activated by CAK,
which phosphorylates T169 (8, 20, 44), and by Mih1 phospha-
tase (35), which dephosphorylates the Y19 residue of Cdc28
that is phosphorylated by Swe1 protein kinase (1). Neither of
these factors was responsible for the activation of recombinant
Cln2MH6-Cdc28HA because yeast extract efficiently promoted
Cln2MH6-Cdc28HA activation even in the absence of ATP and
in the presence of the potent phosphatase inhibitors sodium
fluoride and sodium orthovanadate (data not shown). More-
over, immunopurified Cln2MH6-Cdc28HA complexes could be
activated in the absence of crude lysate (see Fig. 3C).
The yeast extract Cln2-Cdc28 activator is Cks1. In prelim-
inary attempts to characterize the Cln2MH6-Cdc28HA activator
in yeast extract, we tested its sensitivity to heat. Surprisingly,
boiled yeast extract fully retained its ability to activate baculo-
virus-expressed Cln2MH6-Cdc28HA (Fig. 2A). Eukaryotic cells
express a small protein that binds tightly to the CDK subunit of
cyclin-CDK complexes and that is known by a variety of names
including p13, suc1, and Cks (3, 14, 33). Depending on the
species, p13suc1 or Cks1 ranges in size from 9 to 19 kDa. Given
that the S. pombe p13suc1 protein is heat stable (39), we tested
whether the Cln2MH6-Cdc28HA activator might correspond to
Cks1, which is the budding yeast homolog of p13suc1 (14).
Untreated or boiled E. coli extract that contained Cks1 could
substitute for yeast extract to activate Cln2MH6-Cdc28HA com-
plexes in insect cell lysate (Fig. 2A), whereas control E. coli
extract had no effect (not shown). Half-maximal activation of
Cln2MH6-Cdc28HA complexes in crude Sf9 cell extracts (Fig.
2C) was obtained with ;100 nM purified Cks1 (Fig. 2B). Based
on these observations, we conclude that the heat-stable
Cln2MH6-Cdc28HA activator present in yeast extract is Cks1.
Cks1 assembles with and activates the ability of Cln2-Cdc28
to phosphorylate multiple substrates. Cks proteins are well
known for binding tightly to cyclin B-CDK complexes. To test
if Cks1 likewise assembles with Cln2-Cdc28, all three proteins
were expressed from baculovirus vectors in insect cells. Coo-
massie blue staining and immunoblot analysis confirmed that
Cln2-Cdc28 complexes bound to Cks1 beads (data not shown)
and that both Cln2 and Cks1His6 were recovered along with
GST-Cdc28HA on glutathione resin (Fig. 3A; these complexes
exhibited high histone H1 kinase activity [data not shown]).
These results confirm a previous report that Cdc28 and Cks1
copurify with Cln2 from yeast cells (46).
Histone H1 is a convenient reporter for CDK activity but is
most likely not a physiological substrate for most CDKs. Cln2
(24), Sic1 (45), and Far1 (16) have been implicated as authen-
tic substrates of Cln2-Cdc28 complexes. Thus, we tested
whether recombinant Cln2MH6-Cdc28HA complexes were able
to phosphorylate these substrates and whether phosphoryla-
tion was dependent on Cks1. Cln2MH6-Cdc28HA immunopre-
cipitated from Cks1-treated Sf9 lysates phosphorylated both
histone H1 and the associated Cln2MH6 subunit (Fig. 3B, lane
6, top and middle). In contrast, neither substrate was phos-
phorylated by immunoprecipitates prepared from lysates con-
taining only Cln2MH6 or Cdc28HA (lanes 1 to 4) or from coin-
fected lysates that were not supplemented with Cks1 (lane 5).
Similar results were obtained with Far1 and MBP-Sic1 (Fig.
3C, lanes 1 to 4). Thus, Cks1 activates the ability of Cln2MH6-
Cdc28HA to phosphorylate multiple substrates.
Cks1-dependent activation of Cdc28 is Cln specific. Since
expression of many different cyclin-CDK combinations in Sf9
cells has yielded active protein kinase complexes in the absence
of added Cks proteins, we examined whether the Cks1-depen-
dent activation of Cln2MH6-Cdc28HA was a peculiarity of the
budding yeast CDK or of the G1 cyclin. Whereas coinfection of
Sf9 cells with baculoviruses encoding Cln2MH6 and Cdc28HA
yielded little precipitable protein kinase activity unless Cks1
was added prior to immunoprecipitation with anti-HA anti-
bodies, Sf9 lysates containing Clb4 plus Cdc28HA or Clb5 plus
Cdc28HA yielded substantial histone H1 kinase activity even in
the absence of added Cks1 (Fig. 4). Besides Cln2-Cdc28 com-
plexes, Cln1-Cdc28 complexes expressed in insect cells require
Cks1 for protein kinase activity (38; J. W. Harper, personal
communication).
FIG. 1. Yeast extract activates baculovirus-expressed Cln2-Cdc28 protein ki-
nase. Lysates from Sf9 cells (5 mg) coinfected with recombinant baculoviruses
encoding Cln2MH6 and Cdc28HA were incubated either alone (lane 5) or in the
presence of 18, 54, and 180 mg of extract from Cln-depleted cdc28ts cells (lanes
6 to 8, respectively; relevant genotype: cdc28ts cln1D cln2D cln3D GAL-CLN3). In
a parallel experiment, 180 mg of yeast extract was incubated alone (lane 1) or in
the presence of 2.5, 5, and 7.5 mg of lysate from baculovirus-infected Sf9 cells
expressing Cln2MH6 plus Cdc28HA (lanes 2 to 4, respectively). Following incu-
bation for 15 min at 24°C in the presence of an ATP-regenerating system, all
reaction mixtures were immunoprecipitated with anti-HA monoclonal antibody
12CA5, assayed for histone H1 kinase activity, fractionated on an SDS-polyacryl-
amide gel, and quantitated with a PhosphorImager. Relative kinase activities in
lanes 1 to 8 are 1, 9, 14, 15, 2, 4, 7, and 17, respectively.
FIG. 2. Cks1 activates Cln2-Cdc28 protein kinase. (A) Cks1 substitutes for
yeast extract in the activation of Cln2MH6-Cdc28HA. Extracts prepared from Sf9
cells coinfected with Cln2MH6- and Cdc28HA-expressing baculoviruses were
mixed with the indicated components, incubated at 24°C for 15 min, immuno-
precipitated with anti-HA monoclonal antibody 12CA5, and assayed for histone
H1 protein kinase activity. Relative kinase activities in lanes 1 to 5 are 1, 11, 14,
12, and 14, respectively. U and B, E. coli lysate (40 mg) containing Cks1 or yeast
extract (100 mg) that was either untreated (U) or boiled for 5 min (B). (B)
Purified Cks1. Cks1 (10 mg) purified from E. coli was fractionated on an SDS–
15% polyacrylamide gel and stained with Coomassie blue. (C) Titration of Cks1.
The indicated amounts of Cks1 were mixed with lysate (5 mg) prepared from Sf9
cells coinfected with recombinant baculoviruses encoding Cln2MH6 and
Cdc28HA, and the mixtures were processed as described for panel A. Relative
kinase activities in lanes 1 to 4 are 22, 16, 2, and 1, respectively.
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Cks1 stabilizes Cln2-Cdc28 complexes and can activate pre-
existing complexes. To determine how Cks1 influences the
activity of Cln2MH6-Cdc28HA, we first examined whether Cks1
influences the assembly of the complex. Immunoblotting re-
vealed that greater amounts of Cln2MH6 consistently coimmu-
noprecipitated with Cdc28HA from insect cell lysates that were
supplemented with Cks1 (Fig. 3B, bottom, lane 5 versus lane 6;
Fig. 3C, bottom, lane 3 versus lane 4). Although Cks1 en-
hanced the stability of the Cln2MH6-Cdc28HA complex, there
was substantial Cln2MH6 antigen in Cdc28HA precipitates pre-
pared in the absence of Cks1, even though these precipitates
had little or no protein kinase activity (Fig. 3B and C). The
addition of Cks1 to Cln2MH6-Cdc28HA immunoprecipitates
prepared in the absence of Cks1 led to the appearance of
Cln2MH6-dependent protein kinase activity towards multiple
substrates (Fig. 3C, lanes 5 to 8; note that although the level of
protein kinase activity is higher in lane 4 than in lane 8, there
is significantly less Cln2MH6 in the latter samples). Thus, acti-
vation of Cln2MH6-Cdc28HA by Cks1 can proceed in the ab-
sence of insect cell lysate proteins and ATP. Taken together,
these data suggest that Cks1 has two functions: it can promote
the assembly of Cln2MH6 with Cdc28HA and it can activate
preassembled Cln2MH6-Cdc28HA complexes.
Cks1 is required for Cln2-Cdc28 activity in vivo. Tempera-
ture-sensitive mutant cks1-38 cells arrest cell division in both
G1 and M phases at the nonpermissive temperature (42). To
determine whether Cks1 function is required for the appear-
ance of active Cln2-Cdc28 complexes in vivo, we examined the
level of histone H1 kinase activity associated with epitope-
tagged Cln2 (Cln233HA) in asynchronous and G1-synchronized
populations of CKS1 and cks1-38 cells (Fig. 5). Both histone
H1 kinase activity and Cdc28 antigen were recovered in an-
ti-HA immunoprecipitates prepared from asynchronous pop-
ulations of CKS1 CLN2HA cells (Fig. 5A, lanes 5 and 7) but not
from CKS1 cells that did not express tagged Cln233HA (lanes 1
and 3). In contrast, little or no histone H1 kinase activity and
Cdc28 antigen were detected in anti-HA precipitates prepared
from asynchronous cultures of cks1-38 cells maintained at the
permissive temperature (24°C; lane 9) or shifted to the restric-
tive temperature (38.5°C; lane 11). Immunoblot analysis con-
firmed that these cks1-38 cultures contained normal levels of
Cdc28 and Cln233HA antigens (data not shown). Moreover,
recovery of both Cln233HA-associated protein kinase activity
and Cdc28 antigen was restored by the addition of purified
Cks1 to the cks1-38 lysate prior to the immunoprecipitation
step (Fig. 5A, lanes 10 and 12), indicating that the Cdc28 and
Cln233HA subunits present in cks1-38 cell extracts were com-
petent to form an active kinase complex.
Defective assembly of active Cln2-Cdc28 complexes was also
observed in synchronous G1 phase cultures of cks1-38 cells
(Fig. 5C and D), suggesting that the results observed in Fig. 5A
are not an artifact due to arrest of cks1-38 cells in G2 phase.
Cln233HA expressed in synchronous cultures of G1 phase
cks1-38 cells at 38.5°C migrated upon SDS-PAGE largely as a
hypophosphorylated species relative to the migration seen in
CKS1 cells (Fig. 5C). Given that Cln2 assembled into active
complexes is hyperphosphorylated by Cdc28 (24), this obser-
vation provides further evidence that Cln2-Cdc28 protein ki-
nase activity was dramatically reduced in intact cks1-38 cells.
Although Cln2-Cdc28 protein kinase activity was severely
reduced in cks1-38 cells, precipitation of the same extracts used
above with anti-Clb2 antibodies revealed that these cells con-
tained elevated levels of Clb-associated histone H1 kinase (Fig.
5B, lane 2 versus lane 4). The elevated level of Clb2-Cdc28
activity seen in cks1-38 cells is consistent with the observation
that Cks1 is required for Clb2 turnover (19).
FIG. 3. Cks1 binds to Cln2-Cdc28 and activates phosphorylation of multiple
substrates. (A) Lysates from insect cells coinfected with baculovirus vectors
encoding Cln2, GST-Cdc28HA, and Cks1His6 were adsorbed to glutathione resin,
and specifically bound proteins were revealed by staining with Coomassie blue
(CB) or immunoblotting with anti-His6 antibodies (IB). Arrowheads, migration
of molecular mass markers (from top to bottom, 68, 46, 30, and 21.5 kDa). (B)
Lysates (40 mg) of Sf9 cells infected with recombinant baculoviruses encoding
Cln2MH6 or Cdc28HA, as indicated, were either mock treated or mixed with 390
ng of purified Cks1 for 15 min at 24°C. Reaction mixtures were immunoprecipi-
tated (I.P.) with anti-HA monoclonal antibody 12CA5, and immunoprecipitates
were divided in thirds and assayed for their quantity of histone H1 kinase (top),
Cln2MH6 kinase (middle), or Cln2MH6 antigen (bottom; detected by immuno-
blotting with affinity-purified anti-Cln2 polyclonal antibody). (C) Lanes 1 to 4,
immunoprecipitates prepared as described for panel B were directly assayed for
Far1 or MBP-Sic1 or histone H1 kinase activity. Lanes 5 to 8, Cks1-free immu-
noprecipitates prepared from Sf9 lysates were subdivided into aliquots which
were then either mock treated or supplemented with 390 ng of Cks1. After a brief
incubation, kinase complexes were washed and assayed for Far1, MBP-Sic1, or
histone H1 kinase activity as indicated. All samples were also evaluated by
immunoblotting with an antimyc monoclonal antibody (bottom).
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Cks1 is required for Cln3-Cdc28 activity in vivo. Cks1 is
important for activation of recombinant Cln1-Cdc28 and Cln2-
Cdc28 complexes, and cks1ts cells fail to transit from G1 to S
phase. Given that either Cln1, Cln2, or Cln3 is able to sustain
progression through G1 phase in budding yeast cells (34), we
reasoned that Cks1 might also be important for Cln3-Cdc28
activity. To test this, we examined the formation of active
Cln3-Cdc28 complexes in cks1-38 strains. GAL-CLN333HA
CKS1 and GAL-CLN333HA cks1-38 cells were grown in galac-
tose medium at 25°C and one-half of each culture was shifted
to 38.5°C for 3 h. Cln333HA-Cdc28 activity and Cln333HA plus
Cdc28 antigens were evaluated by protein kinase assay and
immunoblotting of anti-HA immunoprecipitates. Cln333HA-
associated histone H1 kinase activity was substantially dimin-
ished in cks1-38 cells grown at either the permissive or restric-
tive temperature (Fig. 6A). As was observed for Cln2, little
Cdc28 was recovered in Cln3HA precipitates prepared from
cks1-38 cells incubated at the nonpermissive temperature (Fig.
6B). Interestingly, Cdc28 was recovered in association with
Cln3 from cks1-38 cells grown at the permissive temperature
(Fig. 6B), even though these complexes had little protein ki-
nase activity (Fig. 6A). Taken together with the data shown in
Fig. 3C and 5A, this observation suggests that Cks1 stimulates
both the assembly of Cln proteins with Cdc28 and the activity
of preformed Cln-Cdc28 complexes.
The accumulation of Cln3 is negatively regulated by its
Cdc28-dependent phosphorylation (48). Consistent with the
reduced Cln3-associated Cdc28 protein kinase activity de-
tected in vitro, Cln333HA accumulated to high levels, but pri-
marily as hypophosphorylated forms, in cks1-38 cells (Fig. 6C).
DISCUSSION
Cks1 activates budding yeast G1 cyclin-CDK complexes. We
provide evidence that Cks1 is required for the protein kinase
activity of Cln2-Cdc28 and Cln3-Cdc28 protein kinase com-
plexes. Cks1 potently activates the ability of immunoisolated
Cln2-Cdc28 complexes to phosphorylate multiple substrates
but has only a modest effect on the activity of Clb-Cdc28
complexes. Immunoprecipitation experiments suggest that
Cks1 promotes the assembly of active Cln2-Cdc28 complexes
in vivo and in vitro. However, intact Cln2-Cdc28 complexes
recovered from insect cells in the absence of yeast Cks1 are
nonetheless activated by added Cks1, suggesting that Cks1 may
promote Cln2-Cdc28 protein kinase activity by an additional
mechanism besides complex formation.
A previous analysis of the phenotype of cks1-38 mutants
failed to reveal the defect in G1 cyclin-Cdc28 protein kinase
activity reported here (42). This discrepancy is probably due to
the fact that, in the prior work, Cdc28 protein kinase activity
was monitored using an antibody directed against Cdc28. G1
cyclins account for only a small fraction of total Cdc28 protein
kinase activity (47), and Cks1 is not required for the protein
kinase activity of the more abundant Clb-Cdc28 complexes
(Fig. 4 and 5B; the small contribution of Cks1 to Clb-Cdc28
protein kinase activity is probably obscured by the accumula-
tion of Clb2 in cks1-38 cells). Thus, since anti-Cdc28 antibodies
are expected to retrieve both Cln-Cdc28 and Clb-Cdc28 com-
plexes, it is not surprising that Tang and Reed (42) failed to
detect the effect reported here.
Mechanism of Cln2-Cdc28 activation by Cks1. How does
Cks1 promote Cln2-Cdc28 protein kinase activity? First, Cks1
appears to enhance the interaction between Cln2 and Cdc28. It
is difficult to envision how Cks1 stabilizes the interaction of
Cln2 with Cdc28 since Cks1 and cyclin A bind to opposite sides
of Cdk2 and since the binding of Cks1 to the C-terminal lobe
of Cdk2 has little effect on the conformation of the cyclin-
binding interface (2). However, the binding of cyclin B to
p34cdc2 enhances the binding of human Cks2 (7), suggesting
that cyclin and Cks proteins may interact cooperatively with
CDKs. Another possibility is that the long C-terminal tail fol-
lowing the cyclin box of Cln2 may form stabilizing contacts with
Cks1 bound to the carboxy-terminal lobe of Cdc28.
Although Cks1 strongly stabilizes the interaction between
Cln2 and Cdc28 in yeast extract, it has a far less dramatic effect
on the assembly of stable Cln2-Cdc28 complexes in insect cell
extract. We do not understand the reason for this discrepancy.
Perhaps the far greater concentration of Cln2 and Cdc28 sub-
units expressed in insect cells favors complex assembly even if
Cks1 is absent. Alternatively, insect cells may contain a factor
(insect Cks1-like protein?) that stabilizes Cln2-Cdc28 associa-
tion but that is insufficient to sustain protein kinase activity.
Although it is unclear how the binding of Cks1 activates pre-
formed Cln2-Cdc28 complexes isolated from insect cells, it
seems unlikely that this effect is brought about through con-
formational changes propagated from the Cks1 binding site to
the active site of Cdc28, because binding of Cks1 does not
evoke substantial rearrangements within the catalytic site of
Cdk2 (2) and because Cks1 has little effect on the activity of
Clb-Cdc28 complexes.
We suggest four alternative hypotheses to explain how Cks1
selectively activates Cln2-Cdc28 complexes. First, Cln2 may
exert both positive and negative effects on Cdc28. Positive
regulation would presumably be accomplished in the same
manner as is observed for cyclin A: binding of Cln2 rearranges
key residues in the active site of Cdc28, favoring a geometry
that permits transfer of the g phosphate of ATP to bound
substrate (17). In contrast, other domains within Cln2 (e.g., the
C-terminal tail) might act negatively on Cdc28 unless displaced
via binding of Cks1. A second possibility is that Cln proteins
may bind Cdc28 more weakly than do Clb proteins and that
Cks1 may be required to stabilize the Cln-Cdc28 complex.
FIG. 4. Cks1 is not required for protein kinase activity of Clb-Cdc28HA
complexes. Sf9 cells were coinfected with a recombinant baculovirus encoding
Cdc28HA plus an additional virus encoding either Cln2MH6, Clb4, or Clb5, as
indicated. Lysates of infected cells were either mock treated or supplemented
with 390 ng of purified Cks1, incubated at 24°C for 10 min, and immunoprecipi-
tated with anti-HA monoclonal antibody 12CA5. Immunoprecipitates were as-
sayed for their content of histone H1 kinase activity, which was assessed by
SDS-PAGE followed by phosphorimaging. In this experiment, the relative max-
imal H1 kinase activities obtained were 1.0 for Clb4-Cdc28, 0.69 for Cln2-Cdc28,
and 0.42 for Clb5-Cdc28.
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Third, Cks1 may provide substrate interaction sites that are
normally provided by the cyclin in Clb-Cdc28 complexes (21)
but that are otherwise absent from Cln-Cdc28 complexes. Last,
Cks1 may promote Cln2-Cdc28 activity by acting directly on
Cln2. Although it seems likely that the target of action of Cks1
is the a5 helix-L14 loop within the C-terminal lobe of Cdc28,
this last possibility is suggested by the observation that a Cdc28
mutant (Cdc28-1N) that binds Cks1 poorly (2) nonetheless
proceeds through Start and arrests at G2/M instead (32, 41).
Cdc37 has also been reported to promote interactions be-
tween Cln2 and Cdc28 (13). Unlike cdc37-1 mutants, cks1-38
cells contain normal levels of Cdc28 and accumulate high lev-
els of Clb-Cdc28 activity. Cdc37 is thought to promote the
assembly of cyclin-CDK complexes by promoting conforma-
tional maturation of the CDK subunit (10, 40). Thus, Cdc37 and
Cks1 probably promote Cln2-Cdc28 activity by different means.
Is Cks1 required for the activity of other cyclin-CDK com-
plexes? To date, all cyclin-CDK complexes that have been
expressed in insect cells (including cyclin A-Cdc2, cyclin B-
Cdc2, cyclin D-Cdk4, and cyclin E-Cdk2) are active in the
absence of any added proteins (4, 23, 25). Thus, the role of
Cks1 in Cln2-Cdc28 activation may be unique to this particular
combination. However, because mammalian cyclin-Cdk com-
plexes may recruit endogenous Cks1-like proteins in insect
cells, it is possible that mammalian G1 cyclins also require Cks
proteins to activate their cognate CDKs. It is unclear whether
insect cell Cks1-like proteins bind to Cln2-Cdc28, but if they do
they are not sufficient to sustain protein kinase activity in vitro.
There is precedent for assembly factors contributing to the
formation of active cyclin-CDK complexes in animal cells. Be-
sides the Cdc37 example noted above, Mat1 is required for the
assembly of cyclin H-Cdk7 (CAK) complexes (6, 12, 43). Fur-
ther work will be required to test the generality of the obser-
vations we report here and to deduce the exact mechanism by
which Cks1 promotes the activation of Cln2-Cdc28 complexes.
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FIG. 5. Mutant cks1-38 cells fail to assemble active Cln2-Cdc28 protein kinase complexes. (A) Absence of active Cln233HA-Cdc28 complexes in cks1-38 cell extract.
Total cell extract proteins (3 mg) prepared from CLN2 CKS1, CLN233HA CKS1, and CLN233HA cks1-38 cells grown at either the permissive (P; 24°C) or restrictive
(R; 38.5°C) temperature were immunoprecipitated (IP) with anti-HA monoclonal antibody 12CA5, and immunoprecipitates were divided in half and assayed for their
content of histone H1 kinase activity (top) or Cdc28 antigen (bottom). Samples in even-numbered lanes were supplemented with 3.9 mg of purified Cks1 prior to the
immunoprecipitation step. Relative kinase activities in lanes 1 to 12 (top) are 1, 1, 2, 1, 25, 29, 15, 23, 2, 20, 2, and 8, respectively. (B) cks1-38 extracts contain high
levels of Clb2-Cdc28 kinase activity. Total cell extract proteins (1 mg) from the experiment described for panel A were incubated with anti-Clb2 affinity-purified
polyclonal antibodies, and immunoprecipitates were assayed for their content of histone H1 kinase activity. MBP-Clb2, same as sample shown in lane 1, except 20 mg
of purified MBP-Clb2 was added prior to the immunoprecipitation step; 33 a-Clb2, same as sample shown in lane 1, except threefold more antibody was used. These
two controls indicate that immunoprecipitation was specific and that the antibody was used at saturating levels for the assays depicted in lanes 1 to 4. The relative protein
kinase activities in lanes 1 to 6 are 18, 6, 24, 36, 1, and 13, respectively. (C) Accumulation of phosphorylated Cln233HA is strongly delayed in cks1-38 cells released from
a pheromone arrest. CKS1 (odd-numbered lanes) and cks1-38 (even-numbered lanes) cultures were arrested in G1 phase with a-factor, shifted to 38.5°C for 1 h, and
then released by being washed into medium lacking a-factor at 38.5°C. Lysates (100 mg) prepared from cells withdrawn at the indicated times were fractionated by
SDS-PAGE and immunoblotted with anti-HA monoclonal antibody 12CA5 to detect Cln233HA. Note that both the level and phosphorylation state of Cln2 are
diminished in cks1-38 cells. (D) Cln233HA-Cdc28 activity fails to accumulate in cks1-38 cells released from a pheromone arrest. Samples (3 mg) from the experiment
shown in panel C were immunoprecipitated with 12CA5. Immunoprecipitates were assayed for their content of histone H1 kinase activity, which was evaluated by
SDS-PAGE followed by phosphorimaging.
FIG. 6. Mutant cks1-38 cells fail to assemble active Cln3-Cdc28 protein ki-
nase complexes. (A) GAL-CLN333HA CKS1 and GAL-CLN333HA cks1-38 cul-
tures grown in galactose medium at 25°C were split, and half of each culture was
shifted to 38.5°C for 3 h. Total cell extract proteins (10 mg) prepared from cells
maintained at 25°C (P) or shifted to 37°C (R) were immunoprecipitated with
anti-HA monoclonal antibody 12CA5, and immunoprecipitates were divided in
thirds and assayed for their content of Cdc28 (B) and Cln333HA antigens (not
shown) by immunoblotting and for histone H1 kinase activity (A). Kinase activity
shown in panel A is normalized to Cln333HA levels. (C) Cln333HA present in
total cell lysate of untagged controls (lanes 1 and 4), GAL-CLN333HA CKS1 cells
(lanes 2 and 3), and GAL-CLN333HA cks1-38 cells (lanes 5 and 6) was evaluated
by immunoblotting with anti-HA.
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